Login / Signup

Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study.

Maissa JanbainNathalie EnjolrasJean-Claude BordetRadu BolbosMarie BrevetCindy LeissingerDargaud Yesim
Published in: Journal of thrombosis and haemostasis : JTH (2019)
Our results suggest a potential benefit of TXA when used in combination with FVIII in prophylactic settings.
Keyphrases
  • early onset
  • stem cells
  • human health
  • mesenchymal stem cells
  • bone marrow